Back to search
Glymab Therapeutics Limited
16538942
active
Private Limited Company
england wales
Health Score
65 / 100
Some Concerns
25/30
Filing
0/30
Financial
40/40
Risk
No risk factors detected.
Details
THE BELLHOUSE BUILDING SANDERS ROAD, OXFORD, OX4 4GD
Incorporated 24/06/2025
Compliance
Next accounts due
24/03/2027
On track
Confirmation statement
Last:
Due 07/07/2026
On track
Industry
72110
Research and experimental development on biotechnologyOfficers
Mr Phillip John L'Huillier
director · Since 24/06/2025
CEO
NEW ZEALANDER · ENGLAND · Age 64
Also on 1 other board
Professor Linda Gillian Durrant Bsc Phd Prof
director · Since 25/06/2025
SCIENTIST
BRITISH · ENGLAND · Age 68
Also on 5 other boards
Alexander Hayward
secretary · Since 24/04/2026
Persons with Significant Control
Scancell Holdings Plc
75–100% shares
75–100% votes
Appoint directors
Bellhouse Building, Sanders Road, Oxford, OX4 4GD
Reg: 06564638 · United Kingdom · Plc
Notified 24/06/2025